Immatics Final logo (R)_white_background.png
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
July 18, 2024 09:00 ET | https://immatics.com/
Houston, Texas and Tuebingen, Germany, July 18, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T...
22157.jpg
U.S. mRNA Synthesis Raw Materials (Capping Agents, Nucleotides, Plasmid DNA) Market Research 2024-2030: Growing Academic & Industrial Interest in MRNA Technology to Bolster Growth
July 10, 2024 10:28 ET | Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report, Type (Capping Agents, Nucleotides, Plasmid DNA), Application...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
July 10, 2024 08:00 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
Wael-Photo-1
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
July 10, 2024 07:30 ET | Longeveron
Longeveron® Announces U.S. FDA Grants Lomecel-B(TM) Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
Global Cell Therapy Packaging Market
Cell Therapy Packaging Market, 2035 - 48% Vials and 67% Plastic Products, with EVA and Polypropylene Leading Fabrication Materials
July 10, 2024 07:28 ET | Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Packaging Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed, Package Engineering Design,...
NM Professional Pic
Neha Motwani Elected to Longeveron® Board of Directors
July 09, 2024 09:00 ET | Longeveron
Neha Motwani, a senior healthcare investment banker, has been elected to the Longeveron Board of Directors
1-primary-large-dark.jpg
Abata Therapeutics Announces FDA Clearance of Investigational New Drug Application for Clinical Evaluation of ABA-101 in Progressive Multiple Sclerosis
July 09, 2024 06:00 ET | Abata
Abata Therapeutics Announces FDA Clearance of Investigational New Drug Application for Clinical Evaluation of ABA-101 in Progressive Multiple Sclerosis
Roger Hajjar_Ring_6483 - Cropped Headshot
Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors
July 08, 2024 09:00 ET | Longeveron
Gene therapy pioneer Dr. Roger Hajjar elected to Longeveron Board of Directors as company advances it novel cellular therapy across multiple indications.
NurExone logo2.png
Updates from NurExone: Growth Conference Presentation and Website Relaunch
July 05, 2024 08:43 ET | NurExone Biologic Inc
TORONTO and HAIFA, Israel, July 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company,...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
July 02, 2024 16:05 ET | Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and...